Efficacy and safety of 40 mg or 60 mg duloxetine in <scp>J</scp>apanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study

Abstract

This is the first publication of a long-term study carried out in Asia with an entirely Japanese patient population to suggest that long-term duloxetine therapy for diabetic neuropathic pain is effective and has an acceptable safety profile.